✦ LIBER ✦

PCN29 Budgetary Impact of Adoption of Erlotinib for Lung Cancer in the Private Health Insurance Market in Brazil: A Real World Data Analysis

✍ Scribed by Clark, O.; Clark, L.G.O.; Botrel, T.E.A.; Medina, P.; Paladini, L.; Rosa, B.; Rodrigues, N.; Fortes, A.F.; Castro, A.P.; Faleiros, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN35 Capecitabine for the Treatment of

✍ Clark, O.; Clark, L.G.O.; Botrel, T.E.A.; Paladini, L.; Medina, P.; Rosa, B.; Fi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PCN28 Capecitabine for the Treatment of

✍ Clark, O.; Clark, L.G.O.; Botrel, T.E.A.; Rosa, B.; Medina, P.; Paladini, L.; Fi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCN32 COST-MINIMISATION ANALYSIS OF ERLO

✍ S Stefani; MG Saggia; EA Santos 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB